United States Army Acquisition Corps

Picard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded Company via Merger with Altitude Acquisition Corp.

Retrieved on: 
Lunedì, Aprile 24, 2023

PALO ALTO, Calif. and TUCSON, Ariz. and ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (“Picard Medical”), the parent company of SynCardia Systems, LLC (“SynCardia”), a global leader in mechanical heart replacement technology, today announced that it has entered into a definitive business combination agreement with Altitude Acquisition Corp. (“Altitude”) (NASDAQ: ALTU), a publicly traded special purpose acquisition company, that will result in Picard Medical becoming a publicly listed company.

Key Points: 
  • Upon closing of the transaction, Altitude will be renamed Picard Medical Holdings, Inc. and is expected to remain listed on Nasdaq.
  • SynCardia is working with regulatory authorities to have its CE mark reinstated under EU MDR for most European Union countries.
  • Cardiovascular disease is the leading cause of death globally and has resulted in 64.3 million heart failure patients worldwide.
  • The only definitive therapy for end-stage heart failure is heart transplantation, and it is estimated that 300,000 patients currently require this treatment option.

5D Acquisition Corp. Announces Closing of Initial Public Offering

Retrieved on: 
Venerdì, Aprile 14, 2023

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2023) - 5D Acquisition Corp. (TSXV: FIVD.P) ("5D" or the "Corporation") is pleased to announce that it has successfully completed its initial public offering (the "Offering") raising gross proceeds of $312,900 pursuant to an amended and restated final prospectus dated January 20, 2023 (the "Prospectus").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - April 14, 2023) - 5D Acquisition Corp. (TSXV: FIVD.P) ("5D" or the "Corporation") is pleased to announce that it has successfully completed its initial public offering (the "Offering") raising gross proceeds of $312,900 pursuant to an amended and restated final prospectus dated January 20, 2023 (the "Prospectus").
  • The Shares are listed on the TSX Venture Exchange (the "Exchange") and are currently halted pending the satisfaction of certain customary closing conditions.
  • The Corporation expects that the halt will be lifted and that trading will commence on or about April 18, 2023 under the stock symbol FIVD.P.
  • Research Capital Corporation (the "Agent") acted as the lead agent for the Offering.

WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date

Retrieved on: 
Venerdì, Aprile 14, 2023

Cambridge, MA, April 14, 2023 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (NASDAQ: WINV, the “Company”), a special purpose acquisition company, announced today that its Board of Directors (the “Board”) has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from April 17, 2023 to May 17, 2023 (the “Termination Date”), as permitted under the Company’s Amended and Restated Certificate of Incorporation, as amended.

Key Points: 
  • Cambridge, MA, April 14, 2023 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (NASDAQ: WINV, the “Company”), a special purpose acquisition company, announced today that its Board of Directors (the “Board”) has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from April 17, 2023 to May 17, 2023 (the “Termination Date”), as permitted under the Company’s Amended and Restated Certificate of Incorporation, as amended.
  • The purpose of the extension is to provide additional time for the Company to complete an initial business combination.
  • In connection with the extension, $125,000 (representing approximately $0.066 per unredeemed share of common stock issued in the Company’s initial public offering) will be deposited into the trust account established in connection with the Company’s initial public offering.
  • The Board may elect to further extend the Termination Date on a monthly basis until June 17, 2023 upon the deposit of an additional $125,000 into the trust account per monthly extension.

Cascadia Acquisition Corp. Announces Termination of Business Combination Agreement with RealWear

Retrieved on: 
Martedì, Aprile 11, 2023

Cascadia Acquisition Corp. (Nasdaq: CCAI) (“Cascadia”), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that its previously announced business combination agreement with RealWear, Inc. and certain other parties has been terminated in accordance with the terms of the agreement.

Key Points: 
  • Cascadia Acquisition Corp. (Nasdaq: CCAI) (“Cascadia”), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that its previously announced business combination agreement with RealWear, Inc. and certain other parties has been terminated in accordance with the terms of the agreement.

Colombier Acquisition Corp. Announces Filing of a Registration Statement on Form S-4 in Connection with its Combination with PublicSq.

Retrieved on: 
Venerdì, Aprile 7, 2023

Colombier also announced that it has retained Cantor Fitzgerald & Co. (“Cantor Fitzgerald”) as a capital markets advisor on the Business Combination.

Key Points: 
  • Colombier also announced that it has retained Cantor Fitzgerald & Co. (“Cantor Fitzgerald”) as a capital markets advisor on the Business Combination.
  • Cantor Fitzgerald, a leading global financial services group, has agreed to provide certain capital markets advisory services to Colombier related to the transaction.
  • entered into a definitive business combination agreement (the “Business Combination Agreement”).
  • The transaction contemplated by the Business Combination Agreement has been approved by the Colombier Board of Directors and remains subject to stockholder approval, and other customary closing conditions.

Near Intelligence Announces Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Martedì, Marzo 28, 2023

Near Intelligence, Inc. (Nasdaq: NIR) (“Near” or the “Company”), a global leader in privacy-led data intelligence on people, places and products, today announced financial results for the fourth quarter and full year ended December 31, 2022.

Key Points: 
  • Near Intelligence, Inc. (Nasdaq: NIR) (“Near” or the “Company”), a global leader in privacy-led data intelligence on people, places and products, today announced financial results for the fourth quarter and full year ended December 31, 2022.
  • Gross Profit: Gross profit for the fourth quarter of 2022 was $10.7 million, compared to $10.3 million for the fourth quarter of 2021.
  • Gross margin for the fourth quarter of 2022 was 70.0%, compared to 70.5% for the fourth quarter of 2021.
  • Near will host a conference call today, March 28, 2023, to review its fourth quarter and full year 2022 financial results and to discuss its financial outlook.

Colonnade Acquisition Corp. II Confirms Redemption of Shares at $10.23 Per Share

Retrieved on: 
Giovedì, Marzo 23, 2023

Colonnade Acquisition Corp. II (NYSE: CLAA) (the “Company”) confirms its previously announced redemption of all of its outstanding Class A ordinary shares (the “Class A Shares”) will occur on March 27, 2023.

Key Points: 
  • Colonnade Acquisition Corp. II (NYSE: CLAA) (the “Company”) confirms its previously announced redemption of all of its outstanding Class A ordinary shares (the “Class A Shares”) will occur on March 27, 2023.
  • The per-share redemption price for the public shares (the “Redemption Amount”) is expected to be approximately $10.23.
  • Beneficial owners of Class A Shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount.
  • All statements other than statements of historical fact included in this press release are forward-looking statements, including, without limitation, the redemption of the Company’s public shares.

Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination

Retrieved on: 
Giovedì, Marzo 23, 2023

Graf Acquisition Corp. IV (NYSE: GFOR) (“Graf”), a NYSE-listed special purpose acquisition company founded by serial SPAC founder James Graf, and NKGen Biotech, Inc. (“NKGen Biotech”), a biotechnology company focused on harnessing the power of the body’s immune system through the development of natural killer cell therapies, announced today that they have signed a non-binding letter of intent (the “LOI”) to pursue a business combination.

Key Points: 
  • Graf Acquisition Corp. IV (NYSE: GFOR) (“Graf”), a NYSE-listed special purpose acquisition company founded by serial SPAC founder James Graf, and NKGen Biotech, Inc. (“NKGen Biotech”), a biotechnology company focused on harnessing the power of the body’s immune system through the development of natural killer cell therapies, announced today that they have signed a non-binding letter of intent (the “LOI”) to pursue a business combination.
  • Based in Santa Ana, CA, NKGen Biotech was established in 2017 and is focused on natural killer cell therapies for the treatment of patients in areas such as neurodegenerative disease (e.g., Alzheimer’s and Parkinson’s) and oncology.
  • NKGen Biotech is currently led by CEO Paul Y.
  • Graf expects to announce additional details regarding the proposed business combination when a definitive merger agreement is executed.

Data Intelligence Firm, Near, to Debut on Nasdaq Under Ticker “NIR”

Retrieved on: 
Giovedì, Marzo 23, 2023

Near’s solutions are designed to enhance customer revenue and return on investment through the use of data-driven intelligence.

Key Points: 
  • Near’s solutions are designed to enhance customer revenue and return on investment through the use of data-driven intelligence.
  • The Near platform curates one of the world’s largest sources of intelligence on people, places, and products.
  • Near processes data from an estimated 1.6 billion unique user IDs and 70 million points of interests, in more than 44 countries.
  • “We have a bold vision for Near - to help global enterprises better understand consumer behavior by providing them with actionable intelligence.”

BlueRiver Acquisition Corp. to Complete Transfer of Listing To NYSE American

Retrieved on: 
Martedì, Marzo 21, 2023

BlueRiver Acquisition Corp. (NYSE: BLUA) (“BlueRiver”), announced today that it was authorized to transfer its listing from the New York Stock Exchange (the “NYSE”) to the NYSE American LLC (the “NYSE American”).

Key Points: 
  • BlueRiver Acquisition Corp. (NYSE: BLUA) (“BlueRiver”), announced today that it was authorized to transfer its listing from the New York Stock Exchange (the “NYSE”) to the NYSE American LLC (the “NYSE American”).
  • BlueRiver received written confirmation that it received the final approval for listing from the staff of NYSE American on March 21, 2023.
  • In connection with the transfer, BlueRiver will voluntarily delist from the New York Stock Exchange, and expects to begin trading on the NYSE American on or about March 24, 2023.
  • Following the transfer to the NYSE American, BlueRiver intends to continue to file the same types of periodic reports and other information it currently files with the U.S. Securities and Exchange Commission.